Woodline Partners’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $870K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $30.1K | Hold |
|
|||||
|
2024
Q1 | $46.3K | Hold |
|
|||||
|
2023
Q4 | $40.2K | Hold |
|
|||||
|
2023
Q3 | $30.5K | Hold |
|
|||||
|
2023
Q2 | $66K | Hold |
|
|||||
|
2023
Q1 | $48.9K | Hold |
|
|||||
|
2022
Q4 | $72K | Hold |
|
|||||
|
2022
Q3 | $152K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.02M | Hold |
|
|||||
|
2021
Q4 | $1.56M | Sell |
|
|||||
|
2021
Q3 | $3.05M | Sell |
|
|||||
|
2021
Q2 | $8.11M | Buy |
|